enVVeno Medical Corp
NVNO- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001661053
In the last 90 days, enVVeno Medical Corp insiders filed 0 open-market purchases and 1 sale; 17 institutions reported holding it in 13F filings for Q2 2026, worth $953.6K in total; no superinvestor holds it.
13F holders, Q1 2026
Institutional positions in enVVeno Medical Corp as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 17
- −17 vs. Q4 2025
- Shares held
- 100.5K
- −78.2K (−43.8%) vs. Q4 2025Converted for a 1-for-35 split
- Total value
- $1.02M
- −$988.3K (−49.3%) vs. Q4 2025
- New holders
- 6
- 3 more added
- Sold out
- 23
- 5 more reduced
2 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NVNO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 17 | $953.6K |
| Q1 2026 | 17 | $1.02M |
| Q4 2025 | 36 | $2.10M |
| Q3 2025 | 36 | $5.40M |
| Q2 2025 | 37 | $20.3M |
| Q1 2025 | 31 | $9.61M |
| Q4 2024 | 35 | $12.9M |
| Q3 2024 | 36 | $17.5M |
| Q2 2024 | 26 | $17.3M |
| Q1 2024 | 32 | $19.8M |
| Q4 2023 | 30 | $21.8M |
| Q3 2023 | 24 | $10.4M |
| Q2 2023 | 23 | $5.90M |
| Q1 2023 | 18 | $8.50M |
| Q4 2022 | 22 | $8.46M |
| Q3 2022 | 22 | $13.7M |
| Q2 2022 | 21 | $8.11M |
| Q1 2022 | 21 | $13.0M |
| Q4 2021 | 24 | $13.7M |
| Q3 2021 | 16 | $8.74M |
| Q2 2021 | 14 | $6.16M |
| Q1 2021 | 16 | $5.24M |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding enVVeno Medical Corp; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Kingdon Capital Management, L.L.C. | 36,166 | $366.4K | 0.06% | 00.0% | UnchangedConverted for a 1-for-35 split |
| CM Management, LLC | 35,714 | $361.8K | 0.30% | 00.0% | UnchangedConverted for a 1-for-35 split |
| Geode Capital Management, LLC | 10,455 | $105.9K | 0.00% | +4,705+81.8% | AddedConverted for a 1-for-35 split |
| Vanguard Capital Management LLC | 6,287 | $63.7K | 0.00% | +6,287 | New |
| JPMorgan Chase & Co | 5,209 | $52.9K | 0.00% | 00.0% | UnchangedConverted for a 1-for-35 split |
| Vanguard Fiduciary Trust Co | 2,184 | $22.1K | 0.00% | +2,184 | New |
| BlackRock, Inc. | 1,840 | $18.6K | 0.00% | +112+6.5% | AddedConverted for a 1-for-35 split |
| Westside Investment Management, Inc. | 1,589 | $16.1K | 0.00% | −1,058−40.0% | ReducedConverted for a 1-for-35 split |
| Tower Research Capital LLC (TRC) | 542 | $5.49K | 0.00% | +542 | New |
| UBS Group AG | 243 | $2.46K | 0.00% | −675−73.5% | ReducedConverted for a 1-for-35 split |
| Wells Fargo & Company | 114 | $1.16K | 0.00% | +57+99.5% | AddedConverted for a 1-for-35 split |
| Vanguard Global Advisers, LLC | 77 | $780 | 0.00% | +77 | New |
| Morgan Stanley | 76 | $770 | 0.00% | −6−7.4% | ReducedConverted for a 1-for-35 split |
| Advisor Group Holdings, Inc. | 7 | $70 | 0.00% | −0−2.0% | ReducedConverted for a 1-for-35 split |
| Group One Trading, L.P. | 2 | $20 | 0.00% | −48−96.0% | ReducedConverted for a 1-for-35 split |
| Northwestern Mutual Wealth Management Co | 2 | $20 | 0.00% | +2 | New |
| Citigroup Inc | 1 | $10 | 0.00% | +1 | New |
| Perceptive Advisors LLC | 0 | $0 | 0.00% | −50,258−100.0% | Sold outConverted for a 1-for-35 split |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −5,674−100.0% | Sold outConverted for a 1-for-35 split |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −5,110−100.0% | Sold outConverted for a 1-for-35 split |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −4,561−100.0% | Sold outConverted for a 1-for-35 split |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −3,781−100.0% | Sold outConverted for a 1-for-35 split |
| ACT Capital Management, LLC | 0 | $0 | 0.00% | −3,286−100.0% | Sold outConverted for a 1-for-35 split |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −2,659−100.0% | Sold outConverted for a 1-for-35 split |
| Virtu Financial LLC | 0 | $0 | 0.00% | −2,111−100.0% | Sold outConverted for a 1-for-35 split |
| XTX Topco Ltd | 0 | $0 | 0.00% | −1,920−100.0% | Sold outConverted for a 1-for-35 split |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −1,788−100.0% | Sold outConverted for a 1-for-35 split |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −1,466−100.0% | Sold outConverted for a 1-for-35 split |
| HRT Financial LP | 0 | $0 | 0.00% | −1,407−100.0% | Sold outConverted for a 1-for-35 split |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −1,221−100.0% | Sold outConverted for a 1-for-35 split |
| State Street Corp | 0 | $0 | 0.00% | −1,166−100.0% | Sold outConverted for a 1-for-35 split |
| Northern Trust Corp | 0 | $0 | 0.00% | −1,088−100.0% | Sold outConverted for a 1-for-35 split |
| Fermata Advisors, LLC | 0 | $0 | 0.00% | −935−100.0% | Sold outConverted for a 1-for-35 split |
| AQR Capital Management LLC | 0 | $0 | 0.00% | −597−100.0% | Sold outConverted for a 1-for-35 split |
| Creative Planning | 0 | $0 | 0.00% | −597−100.0% | Sold outConverted for a 1-for-35 split |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −400−100.0% | Sold outConverted for a 1-for-35 split |
| Cambridge Investment Research Advisors, Inc. | 0 | $0 | 0.00% | −286−100.0% | Sold outConverted for a 1-for-35 split |
| Bank of America Corp | 0 | $0 | 0.00% | −58−100.0% | Sold outConverted for a 1-for-35 split |
| Wolverine Asset Management LLC | 0 | $0 | 0.00% | −51−100.0% | Sold outConverted for a 1-for-35 split |
| Jones Financial Companies LLLP | 0 | $0 | 0.00% | −1−100.0% | Sold outConverted for a 1-for-35 split |
| Vanguard Group Inc | – | – | – | – | Not filed |
| CIBC Private Wealth Group, LLC | – | – | – | – | Not filed |